Phase 4 N=15 Effect of hCG on Receptivity of the Human Endometrium
Infertility · Subfertility
Primary: Endometrial Staging in hCG Versus Vehicle Treated Patients — 4.0; 4.6; 3.9; 6.5 days — p=<0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=118 Endometrial Injury and Single Embryo Transfer
Primary Infertility
Primary: Clinical Pregnancy Rate
N/A N=254 Media, Morphokinetics, and Mosaicism
Embryonic Mosaicism · Embryo Culture Media · Embryo Morphokinetics
Primary: Aneuploidy Rates — 56.1; 62.3 percentage of embryos — p=0.07
N/A N=293 Same Day Oral EC and Implant Initiation
Contraception
Primary: Pregnancy Rate at One-month — 1.96 percentage of participants
Early Phase 1 N=40 Ovarian Function With ENG Implant and UPA Use
Contraception
Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants
N/A N=220 PGT-A Versus Blastocyst Morphology Selection
Pregnancy
Primary: The Percentage of Patients With a Live Birth — 45; 65 Participants
Phase 3 N=95 Labor and Delivery Implant Insertion: A Randomized Controlled Trial
Postpartum Contraception · Family Planning
Primary: Time to Lactogenesis Stage II [Questionnaire] — 65; 67.5 hours
N/A N=34 Uterine Contractions and Mode of Progesterone in Frozen Embryo Transfer (FET) Cycles: Randomized Clinical Trial
Infertility
Primary: Number of Uterine Endometrial Contractions Per Minute — 2.4; 1.4 waves per minute
Phase 4 N=69 Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
Complications; Contraceptive · Female Lactation
Primary: Time to Lactogenesis Stage II — 64.3; 65.2 hours — p=<0.05
Phase 4 N=150 Breastfeeding Etonogestrel Implant Study
Contraception
Primary: Number of Participants With Continuation of Breastfeeding at 8 Weeks Postpartum — 54; 45; 48; 43 Participants
N/A N=120 Endometrial Injury for Unexplained Infertility
Infertility
Primary: Measurement of Uterine Artery Pulsatility Index — 2.40; 2.35 index — p=<0.05
N/A N=661 Single Embryo TrAnsfeR of Euploid Embryo
Infertility · Aneuploidy
Primary: Ongoing Pregnancy — 137; 143 Participants
Phase 4 N=88 'Levonorgestrel IUD Insertion After D&E Procedure
Contraceptive Usage
Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05
N/A N=352 Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF
EMBRYO IMPLANTATION
Primary: Positive Pregnancy Test — 112; 113 Participants
Phase 4 N=59 Immediate vs. Delayed Postpartum Etonogestrel Implant
Continuation Rate of Contraceptive Implant
Primary: Continuation Rate — 20; 18 participants
Phase 2 N=129 Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)
Infertility, Female
Primary: Embryo Implantation and Clinical Pregnancy Rates — 32; 33 Gestational sacs — p=0.72
Phase 3 N=349 Does Endometrial Injury Improve Intrauterine Insemination Outcome?
Infertility
Primary: Chemical Pregnancy Rate — 40; 19 participants
Phase 4 N=109 Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
Bleeding · Implants · Breakthrough Bleeding
Primary: Total Number of Consecutive Bleeding-free Days in First 30 Days From Day 1 of First Treatment (TX1) — 18.5; 8.7 days
Phase 3 N=1,390 Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)
Infertility
Primary: Percentage of Participants With ≥1 Vital Pregnancy (Cumulative Vital Pregnancy Rate) — 31.1; 33.0 Percentage of Participants
Phase 2 N=41 Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
Recurrent Pregnancy Loss · Unexplained Infertility
Primary: Abnormal Microbiome Bacterial Sequencing
N/A N=170 Comparing Two Types of Endometrial Activation Prior to Embryo Transfer
Infertility · Endometrial Disorder
Primary: Number of Participants With Live Births Per Transfers Performed — 37; 43 Participants
Phase 4 N=970 TiLE (Time Lapse Eeva) Clinical Trial
Fertility
Primary: Implantation Rate — 30.1; 35.3 % of sacs per embryo transferred
Phase 4 N=96 Postpartum Etonogestrel Implant for Adolescents
Adolescence · Contraception · Postpartum
Primary: Continuation at 1 Year — 21; 30 participants
Phase 2 N=72 Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women
HIV/AIDS · Contraception
Primary: Proportion of Participants That Ovulate During Month 3 — 11; 0 Participants — p=<.001
N/A N=31 ESS505 Pre-hysterectomy Protocol
Contraception
Primary: Number of Occluded Fallopian Tubes 60 Minutes After Placement of the Insert as Measured by an HSG Evaluation — 36; NA; NA; NA Occluded fallopian tubes
Phase 4 N=29 A Pilot Study of Early Postpartum Intrauterine Contraception
Unplanned Pregnancy
Primary: IUD Expulsion — 11 Participants
Phase 4 N=24 Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone
Reproductive Techniques, Assisted
Primary: Predecidual Transformation — 1; 2; 7; 8 participants — p=0.3395
Phase 2 N=10 Elagolix for Fertility Enhancement Clinical Trial
Endometriosis · Unexplained Infertility
Primary: Number of Live Births — 3; 1 live births
N/A N=377 Coping Intervention After Embryo Transfer
Anxiety · Depression
Primary: Anxiety — 6.279; 6.223; 6.095; 7.302 units on a scale — p=<0.05
Phase 3 N=65 Intervention to End Recurrent Unscheduled Bleeding Trial
Contraception · Bleeding
Primary: Number of Bleeding/Spotting Days With Use of Ulipristal Acetate as Measured by Daily Bleeding Diaries — 7; 12 days — p=0.002